ENT devices are used to diagnose and treat disorders related to ear, nose and throat. Hearing implants are electronic devices implanted into the ear of a deaf or hard to hear person. GlobalData uses proprietary data and analytics to provide a comprehensive report on the hearing implants devices market, including market shares of different players within New Zealand. Buy the latest report here.
Smarter leaders trust GlobalData
In 2021, GlobalData’s Market Model methodology determined that the leading player in the hearing implants market in New Zealand was Cochlear followed by MED-EL Elektromedizinische Gerate, Oticon Medical and Advanced Bionics.
Hearing Implant devices transmit sound from the ear to the brain. Cochlear implants, bone anchored hearing implants, Auditory Brainstem Implants and middle ear implants have been tracked under this category. A Cochlear Implant (CI) Bionic ear is a device that can be surgically implanted into a person’s cochlea to stimulate it to enhance or restore hearing. Middle ear implants are used to treat conductive and sensorineural hearing loss. Chlamydia trachomatis Tests are carried out to diagnose infections, which can result in trachoma, lymphogranuloma venereum, nongonococcal urethritis, cervicitis, salpingitis, pelvic inflammatory disease. Nucleic acid amplification tests (NAAT) are the gold standard for detecting Chlamydia trachomatis due to their high sensitivity and specificity.
Following the widespread disruption resulting from the COVID-19 pandemic to the broader medical devices market during 2020 and 2021, the value of the hearing implants devices market within New Zealand was expected to be over $10m in 2021.
For the latest complete market share analysis of hearing implants device market in New Zealand, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
